Integrated polygenic risk score can more accurately identify people at high risk of developing coronary artery disease across diverse ancestries over a commonly used clinical tool. MENLO PARK, Calif., March 16, 2023 /PRNewswire/ — MyOme, Inc., a clinical whole genome platform analysis company and a leader in the development of polygenic risk scores with […]